| 1 |
Regulatory Approval, Reimbursement, and Clinical Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Metastatic Breast Cancer in the Netherlands |
|
|
| Marianne Luyendijk, Hedwig Blommestein, Carin Uyl-de Groot, Sabine Siesling, Agnes Jager |
|
| JAMA Network Open. 2023; 6(2): e2256170 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
PACIFIC in the Real World |
|
|
| Caroline O’Leary, Jarushka Naidoo |
|
| Journal of Thoracic Oncology. 2023; 18(2): 133 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program |
|
|
| D. Bello Roufai, A. Gonçalves, T. De La Motte Rouge, S. Akla, C. Blonz, J. Grenier, J. Gligorov, M. Saghatchian, C. Bailleux, H. Simon, I. Desmoulins, Z. Tharin, E. Renaud, M. Bertho, M-A Benderra, S. Delaloge, L. Robert, P. Cottu, J. Y. Pierga, D. Loirat, A. Bertucci, B. Renouf, F. C. Bidard, F. Lerebours |
|
| Oncogene. 2023; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Compassionate use of
long-acting
cabotegravir plus rilpivirine for people living with
HIV
-1 in need of parenteral antiretroviral therapy
|
|
|
| Ronald D'Amico, Santiago Cenoz Gomis, Riya Moodley, Rodica Van Solingen-Ristea, Bryan Baugh, Erika Van Landuyt, Veerle Van Eygen, Sherene Min, Amy Cutrell, Caroline Foster, Daniella Chilton, Sabine D. Allard, Annemiek Ruiter |
|
| HIV Medicine. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Early Access to Medicines: Use of Multicriteria Decision Analysis (MCDA) as a Decision Tool in Catalonia (Spain) |
|
|
| Montse Gasol, Noelia Paco, Laura Guarga, Josep Ŕngel Bosch, Caridad Pontes, Mercč Obach |
|
| Journal of Clinical Medicine. 2022; 11(5): 1353 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
International Country-Level Trends, Factors, and Disparities in Compassionate Use Access to Unlicensed Products for Patients With Serious Medical Conditions |
|
|
| Paul Aliu, Séverine Sarp, Ramona Reichenbach, Sigrid Behr, Paige Fitzsimmons, Mansurahmad Shamlajee, Surya Prakash Kola, Samantha Nunes Radimerski, Emil Scosyrev |
|
| JAMA Health Forum. 2022; 3(4): e220475 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Educational needs, perception, and perspectives of oncologists regarding compassionate use programs in Asia |
|
|
| Manmohan Singh,Ankita Jain,Wade Fang,Peter Ong,Roberto Uehara,Jingming Zhong |
|
| Current Medical Research and Opinion. 2021; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Access to unlicensed medicines, who should pay when they are not provided for free? |
|
|
| Kieron David Lewis |
|
| Medicine Access @ Point of Care. 2021; 5: 2399202621 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Gene therapy companies have an ethical obligation to develop expanded access policies |
|
|
| Lisa Kearns,Carolyn Riley Chapman,Kenneth I. Moch,Arthur L. Caplan,Tom Watson,Andrew McFadyen,Pat Furlong,Alison Bateman-House |
|
| Molecular Therapy. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Zugelassene Systemtherapien in der Dermatologie |
|
|
| Monika Kleinhans,Carolin Funke-Lorenz,Joachim Dissemond |
|
| Der Hautarzt. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Digital Transformation in Medical Affairs Sparked by the Pandemic: Insights and Learnings from COVID-19 Era and Beyond |
|
|
| Daniel Furtner, Salil Prakash Shinde, Manmohan Singh, Chew Hooi Wong, Sajita Setia |
|
| Pharmaceutical Medicine. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Mepolizumab in a population with severe eosinophilic asthma and corticosteroid dependence: results from a French early access programme |
|
|
| Camille Taillé,Pascal Chanez,Gilles Devouassoux,Alain Didier,Christophe Pison,Gilles Garcia,Jeremy Charriot,Stéphane Bouée,Alina Gruber,Celine Pribil,Arnaud Bourdin,Marc Humbert |
|
| European Respiratory Journal. 2020; 55(6): 1902345 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
Ethics framework for treatment use of investigational drugs |
|
|
| Jan Borysowski,Andrzej Górski |
|
| BMC Medical Ethics. 2020; 21(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
Doxorubicin and Olaratumab Versus Doxorubicin, Ifosfamide, and Mesna for Treatment of Advanced Soft Tissue Sarcomas |
|
|
| Kathryn J. Hammer,Vanessa C. Copeland,Elizabeth T. Loggers,Seth M. Pollack,Michael J. Wagner,Lee D. Cranmer |
|
| American Journal of Clinical Oncology. 2020; 43(6): 446 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
Understanding the challenges and ethical aspects of compassionate use of drugs in emergency situations |
|
|
| PardeepKumar Goyal,Roli Mathur,Bikash Medhi |
|
| Indian Journal of Pharmacology. 2020; 52(3): 163 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 16 |
Compassionate drug use: Current status in India |
|
|
| YashashriC Shetty,Smita Brahma,PS Manjesh |
|
| Perspectives in Clinical Research. 2020; 11(1): 3 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 17 |
To the Editor, A multicenter, open-label, early access treatment protocol for ibrutinib in patients with relapsed or refractory mantle cell lymphoma |
|
|
| Peter Martin,Andre Goy,Radhakrishnan Ramchandren,Lucille Ferrante,Anil Londhe,Tracy McGowan,Nancy L Bartlett |
|
| Journal of Oncology Pharmacy Practice. 2019; 25(4): 1027 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 18 |
What do patients with unmet medical needs want? A qualitative study of patients’ views and experiences with expanded access to unapproved, investigational treatments in the Netherlands |
|
|
| Eline M. Bunnik,Nikkie Aarts |
|
| BMC Medical Ethics. 2019; 20(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 19 |
Alternative access schemes for pharmaceuticals in Europe: Towards an emerging typology |
|
|
| Olga Löblová,Marcell Csanádi,Piotr Ozieranski,Zoltán Kaló,Lawrence King,Martin McKee |
|
| Health Policy. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 20 |
Patterns of Alternative Access: unpacking the Slovak extraordinary drug reimbursement regime 2012-2016 |
|
|
| Olga Löblová,Marcell Csanádi,Piotr Ozieranski,Zoltán Kaló,Lawrence King,Martin McKee |
|
| Health Policy. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 21 |
Expanding Patient Access to Investigational New Drugs |
|
|
| Gail A. Van Norman |
|
| JACC: Basic to Translational Science. 2018; 3(3): 403 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 22 |
Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myeloma |
|
|
| Ajai Chari,Sagar Lonial,Tomer M. Mark,Amrita Y. Krishnan,Keith E. Stockerl-Goldstein,Saad Z. Usmani,Anil Londhe,Delores Etheredge,Sarah Fleming,Baolian Liu,Jon Ukropec,Thomas S. Lin,Sundar Jagannath,Ajay K. Nooka |
|
| Cancer. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 23 |
Physician perspectives on compassionate use in pediatric oncology |
|
|
| Scott Moerdler,Lindy Zhang,Elena Gerasimov,Chong Zhu,Tamar Wolinsky,Michael Roth,Nancy Goodman,Daniel A. Weiser |
|
| Pediatric Blood & Cancer. 2018; : e27545 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 24 |
Identification, Prioritization, and Treatment of Mutations Identified by Next-Generation Sequencing |
|
|
| Aaron S. Mansfield,Ben Ho Park,Michael P. Mullane |
|
| American Society of Clinical Oncology Educational Book. 2018; (38): 873 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 25 |
A retrospective study of trifluridine/tipiracil in pretreated metastatic colorectal cancer patients in clinical practice |
|
|
| Beatrice Borelli,Gemma Zucchelli,Daniele Rossini,Chiara Cremolini,Carlotta Antoniotti,Roberto Moretto,Federica Marmorino,Camilla Colombo,Francesca Vannini,Laura Delliponti,Mario Spione,Elena Ongaro,Gianluca Masi,Isa Maura Brunetti,Elisabetta Pfanner,Lisa Salvatore,Alfredo Falcone |
|
| Colorectal Cancer. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 26 |
An overview of Compassionate Use Programs in the European Union member states |
|
|
| Gayathri Balasubramanian,Suman Morampudi,Pankdeep Chhabra,Arun Gowda,Behsad Zomorodi |
|
| Intractable & Rare Diseases Research. 2016; 5(4): 244 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
